Inovio Pharmaceuticals, Inc. (INO)
1.33
+0.06
(+4.72%)
USD |
NASDAQ |
Sep 01, 16:00
1.33
0.00 (0.00%)
After-Hours: 04:03
Inovio Pharmaceuticals Research and Development Expense (Annual) : 52.79M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 52.79M |
| December 31, 2024 | 77.22M |
| December 31, 2023 | 88.48M |
| December 31, 2022 | 194.35M |
| December 31, 2021 | 259.24M |
| December 31, 2020 | 100.65M |
| December 31, 2019 | 94.59M |
| December 31, 2018 | 95.26M |
| December 31, 2017 | 98.57M |
| December 31, 2016 | 88.71M |
| December 31, 2015 | 57.79M |
| December 31, 2014 | 34.10M |
| Date | Value |
|---|---|
| December 31, 2013 | 21.37M |
| December 31, 2012 | 17.98M |
| December 31, 2011 | 20.03M |
| December 31, 2010 | 13.26M |
| December 31, 2009 | 9.408M |
| December 31, 2008 | 5.750M |
| December 31, 2007 | 9.626M |
| December 31, 2006 | 8.510M |
| December 31, 2005 | 11.45M |
| December 31, 2004 | 6.549M |
| December 31, 2003 | 2.147M |
| December 31, 2002 | 2.466M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Fortress Biotech, Inc. | 11.90M |
| Tonix Pharmaceuticals Holding Corp. | 44.49M |
| Kura Oncology, Inc. | 251.07M |
| Spero Therapeutics, Inc. | 38.47M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |